- ALXN (NASDAQ)
- Last $75.40
- Change 0.60%
- 01.27.12 3:59 PM EST
Investor Relations
Here you will find financial information about Alexion Pharmaceuticals, including recent news, current and historical share price, and electronic copies of our annual report and SEC filings.
Note: Alexion Pharmaceuticals, Inc. provides this data for informational and research purposes only. The data is not intended for trading purposes. Neither Alexion nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
News
- Tuesday, Jan 3, 2012
Alexion to Present at the 30th Annual JP Morgan Healthcare Conference - Wednesday, Dec 28, 2011
Alexion to Acquire Enobia Pharma Corp. and First Potential Treatment for Patients with Hypophosphatasia (HPP) - Monday, Dec 12, 2011
New Data Confirm Hemolysis as Predictor of Thromboembolism and Early Death in Patients with PNH and Demonstrate Need To Test High-Risk Patients for PNH
Events
- Tuesday, Jan 10, 2012 - 7:30 PM ET
30th Annual JP Morgan Healthcare Conference - Thursday, Dec 29, 2011 - 9:00 AM ET
Alexion Call to Discuss Enobia Acquisition - Wednesday, Nov 30, 2011 - 11:30 AM ET
23rd Annual Piper Jaffray Health Care Conference